{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:54:34Z","timestamp":1756191274881},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,15]]},"DOI":"10.7759\/cureus.11488","type":"journal-article","created":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T17:00:06Z","timestamp":1605459606000},"source":"Crossref","is-referenced-by-count":6,"title":["Acute Limb Ischemia: A Rare Complication of COVID-19"],"prefix":"10.7759","author":[{"given":"Sidra A","family":"Hasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayema","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02084-w","article-title":"Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report","volume":"50","author":"Zhou B","year":"2020","unstructured":"Zhou B, She J, Wang Y, Ma X. Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report. J Thromb Thrombolysis. 2020, 50:229-232. 10.1007\/s11239-020-02084-w","journal-title":"J Thromb Thrombolysis"},{"key":"ref2","unstructured":"COVID-19. Public health emergency of international concern (PHEIC) - global research and innovation forum. towards a research roadmap. (2020). Accessed: February 12, 2020: https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/Global_Research_Forum_FINAL_VERSION_for_web_14_feb_2020.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","volume":"8","author":"Jose RJ","year":"2020","unstructured":"Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020, 8:e46-e47. 10.1016\/S2213-2600(20)30216-2","journal-title":"Lancet Respir Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2020.04.483","article-title":"Acute limb ischemia in patients with COVID-19 pneumonia. (Online ahead of print)","volume":"5214","author":"Bellosta R","year":"2020","unstructured":"Bellosta R, Luzzani L, Natalini G, et al.. Acute limb ischemia in patients with COVID-19 pneumonia. (Online ahead of print). J Vasc Surg. 2020, 5214:31080-31086. 10.1016\/j.jvs.2020.04.483","journal-title":"J Vasc Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2020.06.046","article-title":"A case of Covid-19 patient with acute limb ischemia and heparin resistance","volume":"68","author":"Baccellieri D","year":"2020","unstructured":"Baccellieri D, Bilman V, Apruzzi L, et al.. A case of Covid-19 patient with acute limb ischemia and heparin resistance. Ann Vasc Surg. 2020, 68:88-92. 10.1016\/j.avsg.2020.06.046","journal-title":"Ann Vasc Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu B","year":"2020","unstructured":"Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?. J Autoimmun. 2020, 111:102452. 10.1016\/j.jaut.2020.102452","journal-title":"J Autoimmun"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang N","year":"2020","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020, 18:1094-1099. 10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang C","year":"2020","unstructured":"Zhang C, Wu Z, Li J-W, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020, 55:105954. 10.1016\/j.ijantimicag.2020.105954","journal-title":"Int J Antimicrob Agents"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok F","year":"2020","unstructured":"Klok F, Kruip M, van der Meer N, et al.. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020, 191:145-147. 10.1016\/j.thromres.2020.04.013","journal-title":"Thromb Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.semvascsurg.2008.12.004","article-title":"Proper evaluation and management of acute embolic versus thrombotic limb ischemia","volume":"22","author":"O'Connell JB","year":"2009","unstructured":"O'Connell JB, Qui\u00f1ones-Baldrich WJ. Proper evaluation and management of acute embolic versus thrombotic limb ischemia. Semin Vasc Surg. 2009, 22:10-16. 10.1053\/j.semvascsurg.2008.12.004","journal-title":"Semin Vasc Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen G","year":"2020","unstructured":"Chen G, Wu D, Guo W, et al.. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020, 130:2620-2629. 10.1172\/JCI137244","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta P","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, et al.. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020, 395:1033-1034. 10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang N","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020, 18:844-847. 10.1111\/jth.14768","journal-title":"J Thromb Haemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli B","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, et al.. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:2950-2973. 10.1016\/j.jacc.2020.04.031","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID\u201019: a single center experience","volume":"92","author":"Luo P","year":"2020","unstructured":"Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID\u201019: a single center experience. J Med Virol. 2020, 92:814-818. 10.1002\/jmv.25801","journal-title":"J Med Virol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/44979-acute-limb-ischemia-a-rare-complication-of-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:20:14Z","timestamp":1707506414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/44979-acute-limb-ischemia-a-rare-complication-of-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.11488","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,15]]}}}